| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1159/000469153 |
| P698 | PubMed publication ID | 3139400 |
| P2093 | author name string | Kruithof EK | |
| P433 | issue | 2-3 | |
| P921 | main subject | plasminogen | Q107129060 |
| P304 | page(s) | 113-121 | |
| P577 | publication date | 1988-01-01 | |
| P1433 | published in | Enzyme | Q26839796 |
| P1476 | title | Plasminogen activator inhibitors--a review | |
| P478 | volume | 40 |
| Q41821585 | A Case of Unexplained Cerebral Sinus Thrombosis in a 22-Year-Old Obese Caucasian Woman |
| Q45002953 | A cyclopeptidic suicide substrate preferentially inactivates urokinase-type plasminogen activator |
| Q36025557 | Acute alcohol-induced liver injury |
| Q73425316 | Albuminuria is directly associated with increased plasma PAI-1 and factor VII levels in NIDDM patients |
| Q37305691 | Alcoholic liver disease and the potential role of plasminogen activator inhibitor-1 and fibrin metabolism |
| Q47336395 | Alterations in the common pathway of coagulation during weight loss induced by gastric bypass in severely obese patients. |
| Q35200663 | Alterations of hemostatic parameters in the early development of allogeneic hematopoietic stem cell transplantation-related complications |
| Q35960164 | Angiogenin promotes invasiveness of cultured endothelial cells by stimulation of cell-associated proteolytic activities |
| Q35554163 | Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells |
| Q34239823 | Angiotensin, fibrinolysis, and vascular homeostasis |
| Q46011139 | Antiobesity effects of yerba maté extract (Ilex paraguariensis) in high-fat diet-induced obese mice. |
| Q39561337 | Cerebrospinal fluid plasminogen activator inhibitor-1 in patients with neurological disease |
| Q35597576 | Chronic subhepatotoxic exposure to arsenic enhances hepatic injury caused by high fat diet in mice. |
| Q48152991 | Cisplatin resistant glioblastoma cells may have increased concentration of urokinase plasminogen activator and plasminogen activator inhibitor type 1. |
| Q34779140 | Delayed ethanol elimination and enhanced susceptibility to ethanol-induced hepatosteatosis after liver resection |
| Q37318169 | Disappearance and formation rates of microaneurysms in early diabetic retinopathy |
| Q64282122 | Effect of ethanol on lipid metabolism |
| Q40390590 | Endothelial cell proteases: physiological role and regulation |
| Q34405039 | Ethanol and liver: recent insights into the mechanisms of ethanol-induced fatty liver |
| Q37627304 | Expression of uPA, tPA, and PAI-1 in Calcified Aortic Valves. |
| Q47341697 | Expression profiles of fibrinolytic components in nasal mucosa |
| Q43192139 | Getting Old through the Blood: Circulating Molecules in Aging and Senescence of Cardiovascular Regenerative Cells |
| Q24290299 | Identification and cDNA cloning of a novel RNA-binding protein that interacts with the cyclic nucleotide-responsive sequence in the Type-1 plasminogen activator inhibitor mRNA |
| Q47863705 | Immunohistochemical localization of a urokinase-type plasminogen activator system in squamous cell carcinoma of the oral cavity: association with mode of invasion and lymph node metastasis |
| Q34613767 | Importance of mast cells in the pathophysiology of asthma |
| Q73219355 | Inhibition of B16BL6 melanoma invasion by tyrosine and phenylalanine deprivation is associated with decreased secretion of plasminogen activators and increased plasminogen activator inhibitors |
| Q54969476 | Inhibitory role of plasminogen activator inhibitor-1 in invasion and proliferation of HLE hepatocellular carcinoma cells. |
| Q36072526 | Introduction of an RRHR motif into chicken urokinase-type plasminogen activator (ch-uPA) confers sensitivity to plasminogen activator inhibitor (PAI)-1 and PAI-2 and allows ch-uPA-mediated extracellular matrix degradation to be controlled by PAI-1 |
| Q36237406 | Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? |
| Q74462725 | Mast cells are augmented in deep vein thrombosis and express a profibrinolytic phenotype |
| Q34657919 | Mast cells, thrombosis, and fibrinolysis: the emerging concept |
| Q37127404 | Mechanisms and cell signaling in alcoholic liver disease |
| Q40406417 | Mechanisms of physiological fibrinolysis |
| Q41832676 | Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation |
| Q37111703 | Metformin prevents alcohol-induced liver injury in the mouse: Critical role of plasminogen activator inhibitor-1 |
| Q34013442 | Molecular basis of thrombolytic therapy |
| Q37108878 | New role of plasminogen activator inhibitor-1 in alcohol-induced liver injury |
| Q36940906 | Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis |
| Q34461462 | PAI-1 and t-PA/PAI-1 complex potential markers of fibrinolytic bleeding after cardiac surgery employing cardiopulmonary bypass |
| Q33840622 | PAI-1 plays a protective role in CCl4-induced hepatic fibrosis in mice: role of hepatocyte division. |
| Q43991324 | PAI-1 promotes extracellular matrix deposition in the airways of a murine asthma model |
| Q33514135 | PLAUR polymorphisms and lung function in UK smokers |
| Q34992341 | Paediatric cholestatic liver disease: Diagnosis, assessment of disease progression and mechanisms of fibrogenesis. |
| Q47738050 | Plasminogen Activator Inhibitor-1 Is Critical in Alcohol-Enhanced Acute Lung Injury in Mice. |
| Q37093084 | Plasminogen Activators in Endometrial Physiology and Embryo Implantation: A Review |
| Q36223980 | Plasminogen activator inhibitor type I stabilizes vitronectin-dependent adhesions in HT-1080 cells |
| Q34984527 | Plasminogen activator inhibitor-1 deficient mice are protected from angiotensin II-induced fibrosis |
| Q67778785 | Plasminogen activator inhibitors in human tears |
| Q24306230 | Plasminogen activators and inhibitors in the neuromuscular system: III. The serpin protease nexin I is synthesized by muscle and localized at neuromuscular synapses |
| Q57044366 | Plasminogen-binding proteins as an evasion mechanism of the host's innate immunity in infectious diseases |
| Q24634729 | Poxvirus pathogenesis |
| Q73114773 | Primary fibrinolysis during supraceliac aortic clamping |
| Q71065911 | Prognostic relevance of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in gastric cancer |
| Q34768102 | Protease nexin-1 expression is altered in human breast cancer |
| Q35772792 | Regulatory elements involved in constitutive and phorbol ester-inducible expression of the plasminogen activator inhibitor type 2 gene promoter |
| Q42836856 | Remarkable stabilization of plasminogen activator inhibitor 1 in a "molecular sandwich" complex. |
| Q36269761 | Retracted: The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays |
| Q34002766 | Species specificity of plasminogen activation and acquisition of surface-associated proteolytic activity by group C streptococci grown in plasma. |
| Q47098588 | Structural Principles in the Development of Cyclic Peptidic Enzyme Inhibitors |
| Q40927887 | The effects of metformin on cardiovascular risk factors |
| Q40934291 | The plasminogen activation system in tumour invasion and metastasis |
| Q37779898 | The role of fibrinolytic factors in ischaemia |
| Q40939420 | The role of the integrin vitronectin receptor, alpha v beta 3 in melanoma metastasis |
| Q35085325 | The role of the plasminogen activation cascade in glioma cell invasion: a review. |
| Q37835073 | The role of urokinase-type plasminogen activator in aggressive tumor cell behavior |
| Q77162228 | Urokinase plasminogen activator is localized in stromal cells in ductal breast cancer |
| Q51779283 | Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors. |
| Q80076304 | [Comparison of urokinase type plasminogen activators (uPA) and plasminogen activator inhibitors (PAI-1) in primary resection of oral squamous cell carcinoma] |
| Q80076300 | [The prognostic importance of urinase type plasminogen activators (uPA) and plasminogen activator inhibitors (PAI-1) in the primary resection of oral squamous cell carcinoma] |
| Q71899004 | alpha 2-Antiplasmin and plasminogen activator inhibitors in healing human skin wounds |
| Q33735850 | t-plasminogen activator inhibitor-1 polymorphism in idiopathic pulmonary arterial hypertension |
Search more.